Caplin Point Laboratories Limited (CAPLIPOINT) — Financial Results
Caplin Point Laboratories announced that its trading window will close on July 1, 2026, to facilitate finalization of unaudited financial results for the quarter ending June 30, 2026, with reopening 48 hours post-declaration.
About Caplin Point Laboratories Limited (CAPLIPOINT)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
📡 Get AI alerts when CAPLIPOINT files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track CAPLIPOINT — Free💡 Ask AI about this filing
📊 More CAPLIPOINT filings
- Announcement — 11 July 2026 Caplin Point Laboratories announced receipt of a SEBI-mandated confirmation certificate from its reg...
- regulation 31 — 16 June 2026 Caplin Point Laboratories disclosed on April 6, 2026, that no encumbrance on its shares was created ...
- Announcement — 14 May 2026 Caplin Point Laboratories announced that its subsidiary Caplin Steriles received final USFDA approva...
- Announcement — 14 May 2026 Caplin Point Laboratories announced that the audio recording of its Q4 FY2025-26 earnings call held ...
- 🔴 Corporate Action — 14 May 2026 Caplin Point Laboratories announced an interim dividend of INR 4 per share (200% payout) for FY26, w...
🔥 Also filed on 27 June 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
📡 Get AI alerts when CAPLIPOINT files new disclosures
Track CAPLIPOINT filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track CAPLIPOINT — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research